Clinical Trial Update: Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing the effect of pioglitazone on left ventricular diastolic function in type 2 diabetes mellitus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: WITHDRAWN